| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
3
4
1
5
3
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
D
(Sell)
|
Fund Holdings
The fund tracks the MSCI Europe Index with the majority of its holdings located in the United Kingdom.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 0.18 | 0.18 |
| Stocks | 0.04 | 0.04 |
| Bonds | 0.0 | 0.0 |
| Other | 0.24 | 0.24 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 99.54 | 99.54 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Nestle SA | NSRGF | 0.68 | 3.16 |
| HSBC Holdings PLC | HBCYF | 7.93 | 2.66 |
| Novartis AG | NVSEF | 14.18 | 2.25 |
| Roche Holding AG | RHHVF | 21.67 | 2.22 |
| Vodafone Group PLC | VODPF | 15.32 | 1.9 |
| BP PLC | BPAQF | 6.86 | 1.81 |
| Royal Dutch Shell PLC Class A | RYDAF | -1.9 | 1.66 |
| Sanofi | SAN | --- | 1.56 |
| GlaxoSmithKline PLC | GLAXF | 24.67 | 1.56 |
| British American Tobacco PLC | BATS | --- | 1.41 |
